This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Cardiac dysrhythmias
  • /
  • Vernakalant is superior to ibutilide for achieving...
Journal

Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.

Read time: 1 mins
Published:25th Mar 2020
Author: Simon A, Niederdoeckl J, Skyllouriotis E, Schuetz N, Herkner H, Weiser C et al.
Source: Europace
Ref.:Europace. 2016 Mar 22. pii: euw052. [Epub ahead of print]
DOI:10.1093/europace/euw052
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest